NERXBIOSCIENCES.COM: Keyword Density Checker

Total words: 1171 | 2-word phrases: 301 | 3-word phrases: 325 | 4-word phrases: 337

PAGE INFO

Title	Try to keep the title under 60 characters (69 characters) NĒRx BioSciences Inc \| 212 W 10th Street, Indianapolis, IN 46202
Description	Try to keep the meta description between 50 - 160 characters (225 characters) NĒRx BioSciences Inc is a company dedicated to the discovery and development of targeted therapeutics for cancer. Formed in 2009, we specialize in the discovery and early development of novel biopharmaceutical compounds.
Keywords	Meta keywords are not recommended anymore (161 characters) Cancer Research, Medical Research, Cancer Cure, Fighting Cancer, Cancer Treatment Breakthrough, Bio Sciences, Nerx BioSciences, , , , , , , , , , , , , , , , , ,
H1	No H1 tag on the page (0 characters)

#	Keyword	Frequency	Density
1	a new generation of	3	0.89%
2	of targeted therapeutics for	3	0.89%
3	early development of novel	2	0.59%
4	the dna damage response	2	0.59%
5	to the discovery and	2	0.59%
6	dedicated to the discovery	2	0.59%
7	currently being exploited as	2	0.59%
8	not currently being exploited	2	0.59%
9	processes not currently being	2	0.59%
10	cellular processes not currently	2	0.59%
11	new generation of cancer	2	0.59%
12	cancer drugs that target	2	0.59%
13	of cancer drugs that	2	0.59%
14	generation of cancer drugs	2	0.59%
15	our focus is a	2	0.59%
16	focus is a new	2	0.59%
17	targeting the dna damage	2	0.59%
18	being exploited as cancer	2	0.59%
19	is a new generation	2	0.59%
20	specialize in the discovery	2	0.59%
21	development of targeted therapeutics	2	0.59%
22	targeted therapeutics for cancer	2	0.59%
23	therapeutics for cancer formed	2	0.59%
24	for cancer formed in	2	0.59%
25	cancer formed in 2009	2	0.59%
26	formed in 2009 we	2	0.59%
27	and early development of	2	0.59%
28	discovery and early development	2	0.59%
29	the discovery and early	2	0.59%
30	in the discovery and	2	0.59%
31	exploited as cancer therapies	1	0.30%
32	drugs that target specific	1	0.30%
33	our business model is	1	0.30%
34	specific cellular processes not	1	0.30%
35	in the treatment of	1	0.30%
36	used in the treatment	1	0.30%
37	therapies our business model	1	0.30%
38	through collaboration with other	1	0.30%
39	partners our focus is	1	0.30%
40	the dna damaging agent	1	0.30%

#	URL	Whois	Check
1	https://www.facebook.com/nerxbiosciences	Whois	facebook.com
2	https://twitter.com/NerxBioSciences	Whois	twitter.com
3	https://plus.google.com/117895697643406987423/about	Whois	google.com
4	http://www.ncbi.nlm.nih.gov/pubmed/?term=Turchi+JJ%5BAuthor%5D+or+Turchi+John%5BAuthor%5D	Whois	nih.gov
5	http://projectreporter.nih.gov/Reporter_Viewsh.cfm?sl=13ECC1094788C5D17598B8961CAA4A01A2FFCEB861BF	Whois	nih.gov
6	http://www.wthr.com/story/31778835/chuck-pagano-still-strong-four-years-after-leukemia-fight	Whois	wthr.com
7	http://www.wthr.com/story/31778835/chuck-pagano-still-strong-four-years-after-leukemia-fight	Whois	wthr.com
8	http://www.sciencedirect.com/science/article/pii/S0163725816000322	Whois	sciencedirect.com
9	http://www.insideindianabusiness.com/story/39384906/iu-fund-invests-in-drug-company	Whois	insideindianabusiness.com
10	https://www.facebook.com/nerxbiosciences	Whois	facebook.com